Biweekly carboplatin plus gemcitabine as first-line treatment of elderly patients with advanced squamous non-small-cell lung cancer: A multicenter phase I-II trial by the Hellenic Oncology Research Group
Karampeazis, A, Vamvakas, L, Kentepozidis, N, Polyzos, A, Chandrinos, V, Rigas, G, Christofyllakis, Ch, Kotsakis, A, Hatzidaki, D, Pallis, A.G, Georgoulias, V
Published in Clinical lung cancer (01.11.2016)
Published in Clinical lung cancer (01.11.2016)
Get full text
Journal Article
Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)
Kentepozidis, N., Economopoulou, P., Christofyllakis, Ch, Chelis, L., Polyzos, A., Vardakis, N., Koinis, F., Vamvakas, L., Katsaounis, P., Kalbakis, K., Nikolaou, Ch, Georgoulias, V., Kotsakis, A.
Published in Clinical & translational oncology (01.03.2017)
Published in Clinical & translational oncology (01.03.2017)
Get full text
Journal Article